CLINICAL TRIALS PROFILE FOR SYMADINE
✉ Email this page to a colleague
All Clinical Trials for SYMADINE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02025439 ↗ | Amantadine + rTMS as a Neurotherapeutic for Disordered Consciousness | Completed | Edward Hines Jr. VA Hospital | N/A | 2014-02-01 | The purpose of this study is to examine the safety and efficacy of repetitive transcranial magnetic stimulation (rTMS) combined with Amantadine relative to rTMS Alone and Amantadine Alone for persons in chronic states of seriously impaired consciousness. The hypothesis is that provision of rTMS+Amantadine will provide a safe yet synergistic effect that induces or accelerates functional recovery. |
NCT04273737 ↗ | Amantadine in Treating Cognitive & Motor Impairments in Adolescents and Adults With Cerebral Palsy | Recruiting | Columbia University | Phase 4 | 2020-02-28 | Cerebral palsy (CP) is a common childhood-onset disability associated with motor and cognitive impairments, however most research is focused on motor outcomes. The aim of this study is to determine the effects of Amantadine, a dopaminergic agonist, on cognitive function in adolescents and adults with CP. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for SYMADINE
Condition Name
Clinical Trial Locations for SYMADINE
Trials by Country
Clinical Trial Progress for SYMADINE
Clinical Trial Phase
Clinical Trial Sponsors for SYMADINE
Sponsor Name